Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2 (2022)
Attributed to:
Mendelian randomization to hypothesis-free causal inference
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.968317
Publication URI: http://dx.doi.org/10.3389/fimmu.2022.968317
Type: Journal Article/Review
Parent Publication: Frontiers in Immunology